What You Need to Know About Stem Cell Therapy for Dogs

The use of stem cells to promote healing is a growing area of interest in veterinary medicine. Stories of dramatic improvements in dogs with severe osteoarthritis or soft tissue injuries can make this regenerative therapy sound like a miracle cure. However, although early research is promising, particularly for certain orthopedic conditions, important questions remain about appropriate applications and long-term outcomes.

If you’re considering this treatment option for your pet, here’s what you should know about the science, potential benefits, and current limitations of stem cell therapy for dogs.

What Are Stem Cells?

Stem cells are unique, self-renewing cells that, under certain conditions, can change into other types of cells in a process called differentiation. No other cells have this natural flexibility, and stem cells play an important role in maintaining and repairing body tissue.

Stem cells may be totipotent (able to form all cell types, including embryonic tissues), pluripotent (able to form nearly all cell types), or multipotent (able to form multiple related cell types). In veterinary medicine, the current focus is on using adult mesenchymal stem cells (MSCs), which are multipotent.

What Is Stem Cell Therapy for Dogs?

Mesenchymal stem cells are typically harvested from adipose (fat) tissue or bone marrow in dogs. They’re then administered through targeted treatment into parts of the musculoskeletal system, such as bones, cartilage, muscle, ligaments, or tendons.

“It’s important for pet owners to understand that stem cells are thought to help primarily by reducing inflammation within the joint and modifying the immune response, rather than regenerating new cartilage,” Christina Montalbano, VMD, DACVSMR (Canine), CCRP, CVA, CVMMP, CSCC, explains. Montalbano is a Clinical Assistant Professor of Integrative and Mobility Medicine in the department of Comparative, Diagnostic, and Population Medicine, at the College of Veterinary Medicine, University of Florida.

How Effective Is Stem Cell Therapy for Dogs?

The science and research around stem cell treatment for dogs is evolving. Currently, the most common and studied use is intra-articular (joint) injection for canine osteoarthritis. It’s also used for tendon and ligament soft tissue injuries and, less commonly, certain nerve conditions.

Some sources suggest potential benefits for kidney disease, liver disease, cardiomyopathy, or inflammatory skin and gastrointestinal conditions. However, evidence supporting these uses remains limited and often comes from small or preliminary studies.

Christopher W. Frye, DVM, DACVSMR (Canine), Associate Professor and Section Chief of Sports Medicine & Rehabilitation at Cornell University College of Veterinary Medicine, is leading the only FDA-approved stem cell trial for canine and equine musculoskeletal and nervous conditions. He confirms that directly regrowing tissue from injected stem cells is unlikely with current technology. However, he says that there is definite potential to reduce inflammation and pain or support healing in some musculoskeletal conditions.

Stem Cell Therapy Limitations

Dr. Frye points out that while the current data and research is promising, it has limitations. “The reality is that we know very little about the applications of stem cells in veterinary medicine and how best to use them,” he explains. Many studies have small sample sizes, lack control groups, or rely on subjective assessments. Key variables, such as dosing, timing, disease stage, and product type, remain unclear. Also, how dogs respond often depends on disease severity and other individual patient factors.

For these reasons, dog stem cell therapy is generally considered only as one component of a broader management plan rather than a replacement for established treatments such as weight management, rehabilitation, pain medications, and other orthobiologic therapies, such as platelet-rich plasma (PRP).

Encouragingly, Dr. Frye acknowledges that as the research evolves, more targeted therapies are likely to be derived, and he is excited to see what the future holds.

How Do Vets Administer Stem Cell Therapy?

In most cases, veterinarians administer stem cell therapy using a dog’s own cells (autologous therapy), and this involves three main stages.

1. Collection

A veterinarian harvests a small amount of fat tissue under anesthesia, typically from your dog’s abdomen or shoulder.

Bone marrow stem cell collection may be performed relatively quickly under reversible sedation. It’s less invasive than intra-abdominal fat harvesting and requires less intensive lab processing. However, it’s a skilled procedure that requires additional training for most veterinarians.

2. Processing

For autologous stem cells, your dog’s collected tissue is sent to a laboratory, where the stem cells are isolated and expanded (grown). Processing typically takes 2-3 weeks to create a product for canine administration. Stem cells can be cryopreserved for many years in a viable state for future uses without additional harvesting procedures.

3. Injection

Your dog’s processed cells are often injected directly into the affected area. “Stem cells can be administered intra-articular [joints] for osteoarthritis, intra-muscular for muscle injuries, or intra-lesional for a tendon or ligament injury,” Dr. Montalbano says. Indirect applications have also been studied and applied, including intravenous applications.

Dr. Montalbano explains that clinicians sometimes co-inject stem cells for osteoarthritis with other biologic products, such as platelet-rich plasma or hyaluronic acid. Both of these improve treatment efficacy compared with using any of these products alone. However, researchers cannot make strong conclusions regarding therapeutic combinations due to limited published research.

Most direct injections are performed on an outpatient basis while your dog is under sedation. This helps to ensure accurate needle placement and comfort. Vets can perform intravenous (IV) applications on an appropriately-monitored, awake patient.

Aftercare

According to Dr. Montalbano, after care instructions for most direct applications typically involve monitoring the injection site for heat, swelling, or an increase in pain or lameness.